ContractSecond Supplemental Indenture • December 31st, 2009 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledDecember 31st, 2009 Company Industry JurisdictionTHIS SECOND SUPPLEMENTAL INDENTURE, dated as of December 31, 2009 (this “Second Supplemental Indenture”), is by and among CuraGen Corporation (the “CuraGen”), Celldex Therapeutics, Inc. (“Celldex”) and The Bank of New York Mellon (formerly, The Bank of New York), as trustee under the indenture referred to below (the “Trustee”).